Meg Jardine's Publications

About Meg Jardine's Publications

Honorary Professorial Fellow, The George Institute for Global Health
  • Associate Professor, Faculty of Medicine, UNSW Sydney

  • Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Kidney International Date published:

  • Chronic Kidney Disease and Coronary Artery Disease

    Journal of the American College of Cardiology Date published:

  • Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program

    Journal of the American Society of Nephrology Date published:

  • Canagliflozin and Renal Outcomes in Diabetic Nephropathy

    New England Journal of Medicine Date published:

  • Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

    Circulation Date published:

  • Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program

    Diabetologia Date published:

  • Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease

    Annals of Internal Medicine Date published:

  • Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study

    BMC Nephrology Date published:

  • Dietary Sodium Reduction Reduces Albuminuria: A Cluster Randomized Trial

    Journal of Renal Nutrition Date published:

  • Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

    New England Journal of Medicine Date published:

  • Quality of life in caregivers compared with dialysis recipients: The Co-ACTIVE sub-study of the ACTIVE dialysis trial

    Nephrology Date published:

  • Kidney Health Australia - Caring for Australasians with Renal Impairment guideline recommendations for infection control for haemodialysis units

    Nephrology Date published:

  • Physical component quality of life reflects the impact of time and moderate chronic kidney disease, unlike SF-6D utility and mental component SF-36 quality of life: An AusDiab analysis

    Nephrology Date published:

  • Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials

    BMC Cardiovascular Disorders Date published:

  • The impact of progressive chronic kidney disease on health-related quality-of-life: a 12-year community cohort study

    Quality of Life Research Date published:

  • Effect of extended hours dialysis on sleep quality in a randomized trial

    Nephrology Date published: